(HealthDay News) — Compromised restoration of the skin barrier function of closed diabetic foot ulcers (DFUs), as measured by high transepidermal water loss (TEWL), is associated with increased odds ...

Atacicept, an investigational BAFF (B-cell activating factor)/APRIL (a proliferation-inducing ligand) dual inhibitor, significantly reduced proteinuria in patients with immunoglobulin A nephropathy ...

The researchers found that annual observed cardiac mortality exceeded expected from 2020 to 2023: 16 percent higher in 2020, 17 percent higher in 2021 and 2022, and 6 percent higher in 2023. Cardiac ...

Adding an ICI to neoadjuvant chemotherapy can improve pCR rates and may improve OS in patients with MIBC, research suggests.

Higher all-cause and cardiovascular mortality predicted with concurrent hypertension and type 2 diabetes. (HealthDay News) — Adults with concurrent hypertension and type 2 diabetes (T2D) have high ...

Infectious complications can result when early stone intervention prevents adequate antibiotic treatment or when surgical delay allows bacterial persistence. It’s important to optimize stone surgery ...

The FDA has approved Widaplik (telmisartan, amlodipine and indapamide) for the treatment of hypertension, including as initial treatment, to lower blood pressure.

Trial results offer clinically important information on the efficacy and safety of the combination therapy in CKD with type 2 diabetes.

Chronic kidney disease (CKD) and hypertension are common health problems among childhood cancer survivors with potentially life-threatening sequelae.

(HealthDay News) — Combined body mass index (BMI)-body surface area (BSA) obesity is associated with an increased risk for post-kidney transplant (KT) adverse outcomes, according to a study published ...

Adding zilebesiran to a thiazide diuretic or calcium channel blocker may lead to further blood pressure reduction in patients with uncontrolled hypertension. Zilebesiran added to hypertension ...

One-year incidence of psychosocial therapy initiation was 12.6 percent, while incidence of medication initiation was 2.8 percent ...